Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


19.03.2018

3 Am J Gastroenterol
1 Am J Surg
1 Dig Dis Sci
2 Eur J Gastroenterol Hepatol
1 Gut
8 Inflamm Bowel Dis
3 J Crohns Colitis
2 PLoS One
1 Scand J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. VEERAPPAN GR
    Continuing Medical Education Questions: March 2018: Long-Term Safety of In Utero Exposure to Anti-TNFalpha Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
    Am J Gastroenterol. 2018;113:404.
    PubMed     Text format    

  2. JENSEN CB, Angquist LH, Mendall MA, Sorensen TIA, et al
    Childhood body mass index and risk of inflammatory bowel disease in adulthood: a population-based cohort study.
    Am J Gastroenterol. 2018 Mar 13. pii: 10.1038/s41395-018-0031.
    PubMed     Text format     Abstract available

  3. DEEKE SA, Starr AE, Ning Z, Ahmadi S, et al
    Mucosal-luminal interface proteomics reveals biomarkers of pediatric inflammatory bowel disease-associated colitis.
    Am J Gastroenterol. 2018 Mar 12. pii: 10.1038/s41395-018-0024.
    PubMed     Text format     Abstract available


    Am J Surg

  4. MCKENNA NP, Glasgow AE, Cima RR, Habermann EB, et al
    Risk factors for organ space infection after ileal pouch anal anastomosis for chronic ulcerative colitis: An ACS NSQIP analysis.
    Am J Surg. 2018 Mar 6. pii: S0002-9610(18)30234.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  5. FABIAN O, Hradsky O, Drskova T, Mikus F, et al
    Immunohistochemical Assessment of CD30+ Lymphocytes in the Intestinal Mucosa Facilitates Diagnosis of Pediatric Ulcerative Colitis.
    Dig Dis Sci. 2018 Mar 14. pii: 10.1007/s10620-018-5018.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  6. BINKHORST L, Sobels A, Stuyt R, Westerman EM, et al
    Switching to a infliximab biosimilar: short-term results of clinical monitoring in patients with inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2018 Mar 13. doi: 10.1097/MEG.0000000000001113.
    PubMed     Text format     Abstract available

  7. HOEKSTRA J, van Roon AHC, Bekkering FC, van Tilburg AJP, et al
    Decision making and outcome of pregnancies in female patients with inflammatory bowel disease: findings from a community-based practice.
    Eur J Gastroenterol Hepatol. 2018 Mar 14. doi: 10.1097/MEG.0000000000001117.
    PubMed     Text format     Abstract available


    Gut

  8. OKUGAWA Y, Toiyama Y, Kusunoki M, Goel A, et al
    Re: Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study.
    Gut. 2018 Mar 13. pii: gutjnl-2018-316205. doi: 10.1136/gutjnl-2018-316205.
    PubMed     Text format    


    Inflamm Bowel Dis

  9. WILSON A, Tirona RG, Kim RB
    CYP3A4 Activity is Markedly Lower in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:804-813.
    PubMed     Text format     Abstract available

  10. MA C, Fedorak RN, Kaplan GG, Dieleman LA, et al
    Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohn's Disease: Real-world Experience from a Multicenter Cohort Study.
    Inflamm Bowel Dis. 2017;23:833-839.
    PubMed     Text format     Abstract available

  11. BROCHARD C, Siproudhis L, Leveque J, Grouin A, et al
    Factors Associated with Fecal Incontinence in Women of Childbearing Age with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:775-780.
    PubMed     Text format     Abstract available

  12. REZAIE A, Gu P, Kaplan GG, Pimentel M, et al
    Dyssynergic Defecation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2018 Feb 24. pii: 4909412. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. DA SILVA S, Keita AV, Mohlin S, Pahlman S, et al
    A Novel Topical PPARgamma Agonist Induces PPARgamma Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models.
    Inflamm Bowel Dis. 2018 Feb 24. pii: 4909417. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. ZAMORA C, Canto E, Nieto JC, Garcia-Planella E, et al
    Inverse Association Between Circulating Monocyte-Platelet Complexes and Inflammation in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2018 Feb 23. pii: 4908015. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. SHIRAI S, Hara M, Sakata Y, Tsuruoka N, et al
    Immunogenicity of Quadrivalent Influenza Vaccine for Patients with Inflammatory Bowel Disease Undergoing Immunosuppressive Therapy.
    Inflamm Bowel Dis. 2018 Mar 9. pii: 4925593. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. IRVING PM, Iqbal T, Nwokolo C, Subramanian S, et al
    A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Mar 10. pii: 4925788. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Crohns Colitis

  17. CHEN T, Zhou Q, Zhang D, Jiang F, et al
    Effect of Faecal Microbiota Transplantation for Treatment of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Cohort Studies.
    J Crohns Colitis. 2018 Mar 8. pii: 4924729. doi: 10.1093.
    PubMed     Text format     Abstract available

  18. NIELSEN OH, Rejnmark L, Moss AC
    Role of Vitamin D in the Natural History of Inflammatory Bowel Disease.
    J Crohns Colitis. 2018 Feb 24. pii: 4908651. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. EL MOUZAN M, Wang F, Al Mofarreh M, Menon R, et al
    Fungal Microbiota Profile in Newly Diagnosed Treatment-naive Children with Crohn's Disease.
    J Crohns Colitis. 2017;11:586-592.
    PubMed     Text format     Abstract available


    PLoS One

  20. BUHNER S, Hahne H, Hartwig K, Li Q, et al
    Protease signaling through protease activated receptor 1 mediate nerve activation by mucosal supernatants from irritable bowel syndrome but not from ulcerative colitis patients.
    PLoS One. 2018;13:e0193943.
    PubMed     Text format     Abstract available

  21. MIJAC D, Vukovic-Petrovic I, Mijac V, Perovic V, et al
    MDR1 gene polymorphisms are associated with ulcerative colitis in a cohort of Serbian patients with inflammatory bowel disease.
    PLoS One. 2018;13:e0194536.
    PubMed     Text format     Abstract available


    Scand J Gastroenterol

  22. AHLUWALIA B, Moraes L, Magnusson MK, Ohman L, et al
    Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies.
    Scand J Gastroenterol. 2018 Mar 9:1-11. doi: 10.1080/00365521.2018.1447597.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: